Please assess the completion status of the following clinical trial:

Trial Title: Antidepressant Therapy in Treating Bipolar Type II Major Depression

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Meets DSM-IV criteria for Axis I bipolar II disorder~* Meets DSM-IV criteria for Axis I major depressive episode~* Score of 16 on 17-item HAM-D rating scale~* Not taking monoamine oxidase inhibitors (MAOI) for more than 2 weeks prior to study entry~* Willing to use an effective form of birth control throughout the study~Exclusion Criteria:~* History of mania~* Current primary Axis I diagnosis other than bipolar II disorder~* Alcohol or drug dependence within 3 months prior to study entry~* Contraindication to treatment with venlafaxine or lithium~* Unstable medical condition (e.g., thyroid disease, hypertension, or angina pectoris)~* Pregnant or breastfeeding~* Experiencing suicidal thoughts~* Requires hospitalization~* Requires concurrent neuroleptic or MS therapy~* Requires concurrent AD therapy~* Current psychotic features~* Inadequate trial of therapy at the time of initial screening visit~* History of intolerance to either venlafaxine or lithium~* Unlikely to participate in a 36-week trial~* Presence of apparent secondary gain

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- I (Type: EXPERIMENTAL): Antidepressant therapy
- II (Type: ACTIVE_COMPARATOR): Mood stabilizer therapy

Based on this trial design, predict the completion outcome and termination type (if applicable).